CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $48.37, but opened at $50.4270. CochLear shares last traded at $49.07, with a volume of 6,338 shares.
Wall Street Analyst Weigh In
CHEOY has been the subject of several analyst reports. Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research report on Thursday, July 16th. Canaccord Genuity Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 18th. Finally, Zacks Research upgraded shares of CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Six research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, CochLear presently has a consensus rating of “Hold” and a consensus target price of $117.00.
Read Our Latest Stock Analysis on CochLear
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
- Five stocks we like better than CochLear
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
- Chewy’s Sell-Off Puts Its Recurring Revenue Story Back on Trial for Investors
- Insider Sales Eclipse $450M Across 3 AI Winners, With NVIDIA Leading the Pack
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
